Amicus Therapeutics (FOLD) Stock News, Forecasts and Analyst Outlook on Dec. 14, 2025: What’s Driving the Rally?
Amicus Therapeutics (NASDAQ: FOLD) is near a 52-week high after strong results and bullish analyst coverage. Here’s the latest news, forecasts, catalysts, and key risks as of Dec. 14, 2025. As of Sunday, December 14, 2025 (with U.S. markets closed), Amicus Therapeutics, Inc. (NASDAQ: FOLD) is finishing the week in the spotlight after a sharp move higher. The stock last traded around $10.55 on Friday, December 12, after climbing roughly 6.6% on the session and touching an intraday high of $10.85—a level that also marks the top end of its $5.51–$10.85 52‑week range. Yahoo Finance The late-week push has also